(Q38061970)

28 August 2017

1 reference

title

Focus on systemic lupus erythematosus in indigenous Australians: towards a better understanding of autoimmune diseases (English)

1 reference

systemic lupus erythematosus

28 August 2017

main subject

1 reference

F B Vincent

1

1 reference

28 August 2017

P Bourke

2

1 reference

28 August 2017

E F Morand

3

1 reference

28 August 2017

F Mackay

4

1 reference

28 August 2017

D Bossingham

5

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

Internal Medicine Journal

28 August 2017

published in

1 reference

28 August 2017

volume

43

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

227-234

1 reference

Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003.

28 August 2017

cites work

1 reference

The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties

21 January 2018

1 reference

Scleroderma in Australian aborigines.

21 January 2018

1 reference

BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus

21 January 2018

1 reference

Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data

21 January 2018

1 reference

Ethnicity and lupus nephritis: an Australian single centre study

21 January 2018

1 reference

Systemic lupus erythematosus in the far north of Queensland

21 January 2018

1 reference

Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study

21 January 2018

1 reference

Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus

21 January 2018

1 reference

Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: [corrected] contributions of admixture and socioeconomic status to renal involvement

21 January 2018

1 reference

Systemic lupus erythematosus.

21 January 2018

1 reference

Mechanisms of tissue injury in lupus nephritis

21 January 2018

1 reference

[Systemic lupus erythematosus in Martinique: an epidemiologic study].

21 January 2018

1 reference

The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort

21 January 2018

1 reference

Outcomes in African Americans and Hispanics with lupus nephritis.

21 January 2018

1 reference

Incidence of systemic lupus erythematosus. Race and gender differences

21 January 2018

1 reference

The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous Australians

21 January 2018

1 reference

The clinical characterisation of systemic lupus erythematosus in a Far North Queensland Indigenous kindred

21 January 2018

1 reference

Systemic lupus erythematosus (SLE): different prevalences in different populations of Australian aborigines

21 January 2018

1 reference

Socioeconomic disparities in self-reported arthritis for Indigenous and non-Indigenous Australians aged 18-64.

21 January 2018

1 reference

Rheumatic disease and the Australian aborigine

21 January 2018

1 reference

Evolution in HLA-DRB1 and major histocompatibility complex class II haplotypes of Australian aborigines. Definition of a new DRB1 allele and distribution of DRB1 gene frequencies

21 January 2018

1 reference

Incidence and pattern of acute anterior uveitis in Central Australia

21 January 2018

1 reference

Prevalence of uveitis in indigenous populations presenting to remote clinics of central Australia: the Central Australian Ocular Health Study

21 January 2018

1 reference

Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population?

21 January 2018

1 reference

Group A streptococcal infections in children.

21 January 2018

1 reference

Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic

21 January 2018

1 reference

Acute rheumatic fever and rheumatic heart disease in indigenous populations

21 January 2018

1 reference

Autoantigens identified by screening a human heart cDNA library with acute rheumatic fever sera

21 January 2018

1 reference

A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity

21 January 2018

1 reference

BAFF and MyD88 signals promote a lupuslike disease independent of T cells

21 January 2018

1 reference

The innate immune system in SLE: type I interferons and dendritic cells

21 January 2018

1 reference

Potential role of IFNα in adult lupus

21 January 2018

1 reference

Peripheral blood gene expression profiling in Sjögren's syndrome

21 January 2018

1 reference

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

21 January 2018

1 reference

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

21 January 2018

1 reference

Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

21 January 2018

1 reference

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines

21 January 2018

1 reference

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

21 January 2018

1 reference

21 January 2018

Cracking the BAFF code.

1 reference

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

21 January 2018

1 reference

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

21 January 2018

1 reference

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

21 January 2018

1 reference

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

21 January 2018

1 reference

Decreasing incidence and prevalence of rheumatoid arthritis in pima indians over a twenty-five—year period

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/IMJ.12039

1 reference

28 August 2017

1 reference